Emergent BioSolutions Inc. revised earnings guidance for the year 2024. For the year, the company expects total revenues of $1,000 million to $1,100 million compared to previous guidance of $900 million to $1,100 million. Net loss of $148 million to $98 million compared to previous guidance of $183 million to $133 million.